Molecularly Imprinted Polymer Nanoparticles for Reducing Herpes Simplex Virus Type 2 Infection
ACS Omega · 14.07.2026 · 11 (27) · 40932-40947
DOI: 10.1021/acsomega.6c05736 ↗Kurz gefasst
Fachartikel in der Zeitschrift ACS Omega, online erschienen am 29.06.2026. Verfasst von Maliwan Srisuk und 7 weiteren Autor:innen. Beteiligte Einrichtung: Faculty of Medical Technology, Prince of Songkla University, Hat Yai, Songkhla 90110, Thailand. Die Arbeit nennt 33 Literaturangaben. Der Volltext ist frei zugänglich (Open Access, CC BY-NC-ND 4.0). Gefördert von: Thailand Science Research and Innovation, Prince of Songkla University, ASEAN-European Academic University Network.
Abstract (Originalsprache)
High Resolution Image Download MS PowerPoint Slide Molecularly imprinted polymer nanoparticles (nanoMIPs) were synthesized via solid-phase imprinting for the selective recognition and inhibition of herpes simplex virus type 2 (HSV-2). An optimized copolymer composition yielded spherical nanoMIPs with a hydrodynamic diameter of 146 ± 4 nm, comparable to that of HSV-2 virions (94 ± 6 nm). Electrochemical analysis showed a 3-fold higher current shift for HSV-2-imprinted nanoMIPs compared to nonimprinted controls, confirming enhanced binding ability toward HSV-2. The nanoMIPs exhibited highly preferential recognition of HSV-2 over related viruses, with cross-reactivity of 62 ± 2% for HSV-1, 30 ± 1% for human papillomavirus type 16, and less than 3% for hepatitis B virus and dengue virus type 1. The cytotoxicity assay confirmed that the nanoMIPs were biocompatible with Vero cells and human primary peripheral blood mononuclear cells at concentrations up to 2.92 × 10 6 particles/mL. The nanoMIPs significantly reduced HSV-2 infection during the early stages of infection, achieving inhibition efficiencies of 80 ± 1% and 49 ± 3% in virus pretreatment and cotreatment groups, respectively. This antiviral mechanism is attributed to direct binding of nanoMIPs to intact viral particles and masking of viral glycoproteins required for host cell attachment, leading to blocking the infection pathway. The nanoMIPs maintained robust antiviral efficacy under extreme conditions, retaining inhibition efficiencies of 73 ± 6% at pH 4.0, 67 ± 5% at pH 10.0, and 63 ± 2% following autoclave sterilization. These findings demonstrate that nanoMIPs function as highly stable, robust, and selective biomimetic receptors, offering a promising platform for antiviral nanomedicine and the prevention of HSV-2 transmission.
Autor:innen und Institutionen
- Faculty of Medical Technology, Prince of Songkla University, Hat Yai, Songkhla 90110, Thailand.
- Division of Biological Science, Faculty of Science, Prince of Songkla University, Hat Yai, Songkhla 90110, Thailand.
- Center for Genomics and Bioinformatic Research, Faculty of Science, Prince of Songkla University, Hat Yai, Songkhla 90110, Thailand.
- Department of Microbiology, Faculty of Medicine, Khon Kaen University, Khon Kaen 40002, Thailand.
- HPV & EBV and Carcinogenesis Research Group, Khon Kaen University, Khon Kaen 40002, Thailand.
- Department of Physical Chemistry, Faculty for Chemistry, University of Vienna, Vienna 1090, Austria.
ORCID-Profile: Peter A Lieberzeit, Suticha Chunta
Förderung
- Thailand Science Research and Innovation
- Prince of Songkla University
- ASEAN-European Academic University Network
- Bundesministerium f?r Bildung, Wissenschaft und Forschung
- OeAD-GmbH
Zitieren
APA
Srisuk, M., Swangphon, P., Nualla-Ong, A., Pientong, C., Ekalaksananan, T., Khongwichit, S., Lieberzeit, P. A., & Chunta, S. (2026). Molecularly Imprinted Polymer Nanoparticles for Reducing Herpes Simplex Virus Type 2 Infection. ACS Omega, 11(27), 40932-40947. https://doi.org/10.1021/acsomega.6c05736
Vancouver
Srisuk M, Swangphon P, Nualla-Ong A, Pientong C, Ekalaksananan T, Khongwichit S, et al. Molecularly Imprinted Polymer Nanoparticles for Reducing Herpes Simplex Virus Type 2 Infection. ACS Omega. 2026;11(27):40932-40947. doi:10.1021/acsomega.6c05736
BibTeX
@article{Srisuk2026,
author = {Srisuk, Maliwan and Swangphon, Piyawut and Nualla-Ong, Aekkaraj and Pientong, Chamsai and Ekalaksananan, Tipaya and Khongwichit, Soemwit and Lieberzeit, Peter A and Chunta, Suticha},
title = {Molecularly Imprinted Polymer Nanoparticles for Reducing Herpes Simplex Virus Type 2 Infection},
journal = {ACS Omega},
year = {2026},
volume = {11},
number = {27},
pages = {40932--40947},
doi = {10.1021/acsomega.6c05736}
}
EUVIMED